Cargando…

Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?

Cachexia is a syndrome that affects the entire organism and presents a variable plethora of symptoms in patients, always associated with continuous and involuntary degradation of skeletal muscle mass and function loss. In cancer, this syndrome occurs in 50% of all patients, while prevalence increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Renata de Castro, Freire, Paula Paccielli, Coletti, Dario, Seelaender, Marilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884816/
https://www.ncbi.nlm.nih.gov/pubmed/33604297
http://dx.doi.org/10.3389/fonc.2020.617109
_version_ 1783651491275341824
author Gonçalves, Renata de Castro
Freire, Paula Paccielli
Coletti, Dario
Seelaender, Marilia
author_facet Gonçalves, Renata de Castro
Freire, Paula Paccielli
Coletti, Dario
Seelaender, Marilia
author_sort Gonçalves, Renata de Castro
collection PubMed
description Cachexia is a syndrome that affects the entire organism and presents a variable plethora of symptoms in patients, always associated with continuous and involuntary degradation of skeletal muscle mass and function loss. In cancer, this syndrome occurs in 50% of all patients, while prevalence increases to 80% as the disease worsens, reducing quality of life, treatment tolerance, therapeutic response, and survival. Both chronic systemic inflammation and immunosuppression, paradoxically, correspond to important features in cachexia patients. Systemic inflammation in cachexia is fueled by the interaction between tumor and peripheral tissues with significant involvement of infiltrating immune cells, both in the peripheral tissues and in the tumor itself. Autophagy, as a process of regulating cellular metabolism and homeostasis, can interfere with the metabolic profile in the tumor microenvironment. Under a scenario of balanced autophagy in the tumor microenvironment, the infiltrating immune cells control cytokine production and secretion. On the other hand, when autophagy is unbalanced or dysfunctional within the tumor microenvironment, there is an impairment in the regulation of immune cell’s inflammatory phenotype. The inflammatory phenotype upregulates metabolic consumption and cytokine production, not only in the tumor microenvironment but also in other tissues and organs of the host. We propose that cachexia-related chronic inflammation can be, at least, partly associated with the failure of autophagic processes in tumor cells. Autophagy endangers tumor cell viability by producing immunogenic tumor antigens, thus eliciting the immune response necessary to counteract tumor progression, while preventing the establishment of inflammation, a hallmark of cachexia. Comprehensive understanding of this complex functional dichotomy may enhance cancer treatment response and prevent/mitigate cancer cachexia. This review summarizes the recent available literature regarding the role of autophagy within the tumor microenvironment and the consequences eliciting the development of cancer cachexia.
format Online
Article
Text
id pubmed-7884816
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78848162021-02-17 Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link? Gonçalves, Renata de Castro Freire, Paula Paccielli Coletti, Dario Seelaender, Marilia Front Oncol Oncology Cachexia is a syndrome that affects the entire organism and presents a variable plethora of symptoms in patients, always associated with continuous and involuntary degradation of skeletal muscle mass and function loss. In cancer, this syndrome occurs in 50% of all patients, while prevalence increases to 80% as the disease worsens, reducing quality of life, treatment tolerance, therapeutic response, and survival. Both chronic systemic inflammation and immunosuppression, paradoxically, correspond to important features in cachexia patients. Systemic inflammation in cachexia is fueled by the interaction between tumor and peripheral tissues with significant involvement of infiltrating immune cells, both in the peripheral tissues and in the tumor itself. Autophagy, as a process of regulating cellular metabolism and homeostasis, can interfere with the metabolic profile in the tumor microenvironment. Under a scenario of balanced autophagy in the tumor microenvironment, the infiltrating immune cells control cytokine production and secretion. On the other hand, when autophagy is unbalanced or dysfunctional within the tumor microenvironment, there is an impairment in the regulation of immune cell’s inflammatory phenotype. The inflammatory phenotype upregulates metabolic consumption and cytokine production, not only in the tumor microenvironment but also in other tissues and organs of the host. We propose that cachexia-related chronic inflammation can be, at least, partly associated with the failure of autophagic processes in tumor cells. Autophagy endangers tumor cell viability by producing immunogenic tumor antigens, thus eliciting the immune response necessary to counteract tumor progression, while preventing the establishment of inflammation, a hallmark of cachexia. Comprehensive understanding of this complex functional dichotomy may enhance cancer treatment response and prevent/mitigate cancer cachexia. This review summarizes the recent available literature regarding the role of autophagy within the tumor microenvironment and the consequences eliciting the development of cancer cachexia. Frontiers Media S.A. 2021-02-02 /pmc/articles/PMC7884816/ /pubmed/33604297 http://dx.doi.org/10.3389/fonc.2020.617109 Text en Copyright © 2021 Gonçalves, Freire, Coletti and Seelaender http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Gonçalves, Renata de Castro
Freire, Paula Paccielli
Coletti, Dario
Seelaender, Marilia
Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
title Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
title_full Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
title_fullStr Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
title_full_unstemmed Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
title_short Tumor Microenvironment Autophagic Processes and Cachexia: The Missing Link?
title_sort tumor microenvironment autophagic processes and cachexia: the missing link?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884816/
https://www.ncbi.nlm.nih.gov/pubmed/33604297
http://dx.doi.org/10.3389/fonc.2020.617109
work_keys_str_mv AT goncalvesrenatadecastro tumormicroenvironmentautophagicprocessesandcachexiathemissinglink
AT freirepaulapaccielli tumormicroenvironmentautophagicprocessesandcachexiathemissinglink
AT colettidario tumormicroenvironmentautophagicprocessesandcachexiathemissinglink
AT seelaendermarilia tumormicroenvironmentautophagicprocessesandcachexiathemissinglink